Stanford Health Care (SHC) has selected Mariann Byerwalter to serve as its interim president and CEO, effective January 2, 2016. Byerwalter was selected by the SHC Board Transition Committee, a group of 11 leaders in the Stanford medical community (including Byerwalter herself) tasked with finding Rubin's successor. Rubin, who has served as SHC president and CEO for the past five years, will step down at the end of 2015 to accept the role of executive vice president at UnitedHealth Group. Byerwalter has already begun transitioning into her new role to help ensure a smooth changeover.
Byerwalter '82 is currently chair of the Board of Directors of SRI International, and a board member of Stanford Health Care. In addition, she is currently a director on the Boards of Pacific Life Insurance Company; Franklin Resources, Inc.; WageWorks, Inc.; Redwood Trust, Inc.; the Burlington Capital Group; and Lucile Packard Children's Hospital.
"Mariann has a long history of service and commitment to the Stanford community, including serving as chair of Stanford Health Care's Board of Directors for eight of her 15 years on the Board," said John Levin, chairman, Board of Directors, Stanford Health Care. "Given her significant leadership experience, deep understanding of Stanford's culture and exemplary dedication and commitment to the mission of Stanford Health Care, Mariann is uniquely equipped to serve in this interim capacity."
From 1992 through 2012, Byerwalter served three terms on the Stanford University Board of Trustees, where she chaired the Trustee Committee on the Medical Center. In recognition of her dedication, Byerwalter received the 2015 Stanford University Gold Spike Award, Stanford's highest honor for exceptional volunteer service and leadership. Moreover, she was presented the 2015 School of Medicine Dean's Medal in recognition of her significant contributions to advancing Stanford Medicine. The Dean's Medal recognizes individuals whose scientific, medical, humanitarian or other contributions have significantly advanced the mission of Stanford Medicine.
"Mariann Byerwalter is a visionary individual who has worked tirelessly on behalf of Stanford Medicine, helping to provide financial stability and recruit new faculty to lead the enterprise," said Lloyd Minor, MD, dean of the medical school.
Previously, Byerwalter served as chief financial officer and vice president for Business Affairs at Stanford University. Prior to that, she was an entrepreneur. She was a partner and co-founder of America First Financial Corporation, which purchased and turned around EurekaBank. Byerwalter also served as vice president for Strategic Planning and Corporate Development at BankAmerica Corporation. Byerwalter earned a BA from Stanford University and an MBA from Harvard University. Byerwalter has interwoven her career in business, as a banker and entrepreneur, over the last 30 years with her volunteer service at the university.
"It has been an inspiration and a privilege to be part of an organization that has such a broad impact," Byerwalter said recently in a Stanford Daily article.
The Board Transition Committee, formed after Rubin's announcement, is continuing its nationwide search for a permanent successor.